A clinician’s handbook for using ctDNA throughout the patient journey

A clinician’s handbook for using ctDNA throughout the patient journey

Abstract Background The promise of precision cancer medicine presently centers around the genomic sequence of a patient’s tumor being translated into timely, actionable information to inform clinical care. The analysis of cell-free DNA from liquid biopsy, which contains circulating tumor DNA (ctDNA)...

Full description

Bibliographic Details
Main Authors: Samantha O. Hasenleithner, Michael R. Speicher
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Molecular Cancer
Subjects:
Cell-free DNA
Circulating tumor DNA
Liquid biopsy
Next-generation sequencing
Precision oncology
Whole-genome sequencing
Online Access:https://doi.org/10.1186/s12943-022-01551-7

Similar Items

Similar Items